These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15624094)

  • 21. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone.
    Rong JX; Qiu Y; Hansen MK; Zhu L; Zhang V; Xie M; Okamoto Y; Mattie MD; Higashiyama H; Asano S; Strum JC; Ryan TE
    Diabetes; 2007 Jul; 56(7):1751-60. PubMed ID: 17456854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
    Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
    Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability.
    Baranowski M; Blachnio-Zabielska A; Zabielski P; Gorski J
    Arch Biochem Biophys; 2008 Sep; 477(1):86-91. PubMed ID: 18541139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lessons Learned after 25 Years of Studies on the Physiological Roles of the Peroxisome Proliferator-activated Receptor].
    Motojima K
    Yakugaku Zasshi; 2015; 135(10):1083-9. PubMed ID: 26423862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics of metabolic effects of rosiglitazone.
    Seda O; Sedová L; Oliyarnyk O; Kazdová L; Krenová D; Corbeil G; Hamet P; Tremblay J; Kren V
    Pharmacogenomics; 2008 Feb; 9(2):141-55. PubMed ID: 18370844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.
    He J; Xu C; Kuang J; Liu Q; Jiang H; Mo L; Geng B; Xu G
    Metabolism; 2015 Jul; 64(7):826-36. PubMed ID: 25825274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine competes for the peroxisome proliferator-activated receptor nuclear receptors.
    Hayden MR
    J Cardiometab Syndr; 2008; 3(1):70-1. PubMed ID: 18326982
    [No Abstract]   [Full Text] [Related]  

  • 30. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
    Kim HJ; Jung TW; Kang ES; Kim DJ; Ahn CW; Lee KW; Lee HC; Cha BS
    Metabolism; 2007 May; 56(5):676-85. PubMed ID: 17445544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
    Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
    Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta.
    Toba H; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Murakami M; Morita Y; Nakayama Y; Kobara M; Nakata T
    Eur J Pharmacol; 2006 Nov; 549(1-3):124-32. PubMed ID: 16979161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
    Sugiyama Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():416-21. PubMed ID: 12387027
    [No Abstract]   [Full Text] [Related]  

  • 34. Rosiglitazone decreases bone mass and bone marrow fat.
    Harsløf T; Wamberg L; Møller L; Stødkilde-Jørgensen H; Ringgaard S; Pedersen SB; Langdahl BL
    J Clin Endocrinol Metab; 2011 May; 96(5):1541-8. PubMed ID: 21367933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.
    Kang ES; Park SY; Kim HJ; Kim CS; Ahn CW; Cha BS; Lim SK; Nam CM; Lee HC
    Clin Pharmacol Ther; 2005 Aug; 78(2):202-8. PubMed ID: 16084854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glitazones: clinical effects and molecular mechanisms.
    Stumvoll M; Häring HU
    Ann Med; 2002; 34(3):217-24. PubMed ID: 12173692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting adipose tissue angiogenesis to enhance insulin sensitivity.
    Mannerås-Holm L; Krook A
    Diabetologia; 2012 Oct; 55(10):2562-2564. PubMed ID: 22842613
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy.
    Tan GD; Debard C; Funahashi T; Humphreys SM; Matsuzawa Y; Frayn KN; Karpe F; Vidal H
    Diabetologia; 2005 Aug; 48(8):1585-9. PubMed ID: 15991021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of rosiglitazone on the cardiovascular profile in postmenopausal women without diabetes mellitus: interplay of thiazolidinediones and hormone therapy.
    Chen IC; Lee WH; Chao TH; Li YH; Tsai WC; Pan HA; Tseng SY; Chen JY
    Menopause; 2012 Jul; 19(7):812-9. PubMed ID: 22415569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.